SynthesisFrontiers in medicine2026
Effectiveness of long-term graduated compression stockings after deep vein thrombosis: a GRADE-based meta-analysis of randomized controlled trials.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Post-thrombotic syndrome (PTS) is a common long-term complication following deep vein thrombosis (DVT), leading to substantial morbidity and impaired quality of life. Elastic compression stockings (ECS) are widely used for PTS prevention; however, their effectiveness remains controversial, particularly across different severities of PTS. Method: A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to evaluate the effectiveness of ECS in preventing PTS after DVT. Electronic databases were searched from inception to January 20, 2026. The primary outcomes were the overall incidence of PTS at final follow-up, as well as the incidence of mild-to-moderate and severe PTS. Secondary outcomes included recurrent DVT and all-cause mortality. Risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using a random-effects model. The certainty of evidence was assessed using the GRADE approach. Results: Eight trials involving 1,775 patients were included. ECS were associated with a modest reduction in total PTS (RR 0.70; 95% CI 0.51-0.96; absolute reduction ~127 per 1,000), corresponding to an absolute reduction of approximately 142 cases per 1,000 patients. When stratified by severity, ECS reduced mild-to-moderate PTS (RR 0.69; 95% CI 0.50-0.93; absolute reduction ~129 per 1,000), whereas effects on severe PTS were uncertain (RR 0.56; 95% CI 0.22-1.43). No clear impact was observed on recurrent DVT (RR 0.90; 95% CI 0.73-1.11) or all-cause mortality (RR 0.98; 95% CI 0.68-1.40). Certainty of evidence was low for total and mild-to-moderate PTS and very low for severe PTS, recurrent DVT, and mortality. Heterogeneity in adherence, control group design, PTS definitions, and initial DVT management may have influenced outcomes. Conclusion: Long-term ECS may modestly reduce mild-to-moderate PTS after DVT, but their effect on severe PTS, recurrent DVT, and mortality remains uncertain. ECS may improve symptoms, but their preventive effect is limited, and clinical decisions should consider patient-specific factors, adherence, and the multifactorial determinants of PTS. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261386069.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.